112 related articles for article (PubMed ID: 11501843)
1. Diagnostic application of CD44 variant expression in pancreatic juice for detection of pancreatic neoplasm.
Tsukuda H; Matsumura Y; Inoue T; Kobayashi Y; Ookawa K; Aoki T; Nebiki H; Yamazaki O; Kondo H; Kakizoe T
Anticancer Res; 2001; 21(3C):2175-83. PubMed ID: 11501843
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification.
Seki K; Suda T; Aoyagi Y; Sugawara S; Natsui M; Motoyama H; Shirai Y; Sekine T; Kawai H; Mita Y; Waguri N; Kuroiwa T; Igarashi M; Asakura H
Clin Cancer Res; 2001 Jul; 7(7):1976-81. PubMed ID: 11448913
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer.
Ohuchida K; Mizumoto K; Ogura Y; Ishikawa N; Nagai E; Yamaguchi K; Tanaka M
Clin Cancer Res; 2005 Mar; 11(6):2285-92. PubMed ID: 15788678
[TBL] [Abstract][Full Text] [Related]
4. The influence of hormones on CD44 expression in endometrial and breast carcinomas.
Durst B; Sorg RV; Röder G; Betz B; Beckmann MW; Niederacher D; Bender HG; Dall P
Oncol Rep; 2001; 8(5):987-93. PubMed ID: 11496303
[TBL] [Abstract][Full Text] [Related]
5. CD44 variant exon 6 expressions in colon cancer assessed by quantitative analysis using real time reverse transcriptase-polymerase chain reaction.
Yamada Y; Itano N; Narimatsu H; Kudo T; Hirohashi S; Ochiai A; Tohnai I; Ueda M; Kimata K
Oncol Rep; 2003; 10(6):1919-24. PubMed ID: 14534719
[TBL] [Abstract][Full Text] [Related]
6. CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistance.
Klingbeil P; Marhaba R; Jung T; Kirmse R; Ludwig T; Zöller M
Mol Cancer Res; 2009 Feb; 7(2):168-79. PubMed ID: 19208744
[TBL] [Abstract][Full Text] [Related]
7. The splice-pattern of CD44 is altered in chronic pancreatitis exhibiting dysplastic changes.
Gansauge F; Gansauge S; Schlosser W; Schmid R; Adler G; Beger HG
Eur J Med Res; 1998 Sep; 3(9):419-26. PubMed ID: 9737888
[TBL] [Abstract][Full Text] [Related]
8. Progressive loss of CD44 gene expression in invasive bladder cancer.
Sugino T; Gorham H; Yoshida K; Bolodeoku J; Nargund V; Cranston D; Goodison S; Tarin D
Am J Pathol; 1996 Sep; 149(3):873-82. PubMed ID: 8780391
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of CD44 splice variants in human pancreatic adenocarcinoma and in normal pancreas.
Gansauge F; Gansauge S; Zobywalski A; Scharnweber C; Link KH; Nussler AK; Beger HG
Cancer Res; 1995 Dec; 55(23):5499-503. PubMed ID: 7585621
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of human telomerase reverse transcriptase in pancreatic juice as a biomarker of pancreatic malignancy.
Nakashima A; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Ohge H; Oda M; Sueda T; Hiyama E
Pancreas; 2009 Jul; 38(5):527-33. PubMed ID: 19342980
[TBL] [Abstract][Full Text] [Related]
11. Expression of splice variants of CD44 mRNA and its significance in human primary hepatocellular carcinoma.
Liu P; Wu M; Chen H; Qian G; Fu J
Chin Med J (Engl); 1998 Jul; 111(7):603-5. PubMed ID: 11245045
[TBL] [Abstract][Full Text] [Related]
12. Detection of human telomerase reverse transcriptase (hTERT) expression in tissue and pancreatic juice from pancreatic cancer.
Hashimoto Y; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Fukuda E; Sueda T; Hiyama E
Surgery; 2008 Jan; 143(1):113-25. PubMed ID: 18154939
[TBL] [Abstract][Full Text] [Related]
13. CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma.
Rall CJ; Rustgi AK
Cancer Res; 1995 May; 55(9):1831-5. PubMed ID: 7537174
[TBL] [Abstract][Full Text] [Related]
14. Significant overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma using real-time quantitative reverse transcription polymerase chain reaction.
Nielsen A; Scarlett CJ; Samra JS; Gill A; Li Y; Allen BJ; Smith RC
J Gastroenterol Hepatol; 2005 Feb; 20(2):256-63. PubMed ID: 15683429
[TBL] [Abstract][Full Text] [Related]
15. The establishment of the duplex real-time RT-PCR assay for the detection of CD44v6 in pancreatic cancer patients and clinical application.
Zhou G; Chiu D; Qin D; Niu L; Cai J; He L; Huang W; Xu K
Biotechnol Appl Biochem; 2012; 59(1):55-63. PubMed ID: 22332746
[TBL] [Abstract][Full Text] [Related]
16. CEACAM1, a novel serum biomarker for pancreatic cancer.
Simeone DM; Ji B; Banerjee M; Arumugam T; Li D; Anderson MA; Bamberger AM; Greenson J; Brand RE; Ramachandran V; Logsdon CD
Pancreas; 2007 May; 34(4):436-43. PubMed ID: 17446843
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of ADAM 9 and ADAM 15 mRNA in pancreatic cancer.
Yamada D; Ohuchida K; Mizumoto K; Ohhashi S; Yu J; Egami T; Fujita H; Nagai E; Tanaka M
Anticancer Res; 2007; 27(2):793-9. PubMed ID: 17465204
[TBL] [Abstract][Full Text] [Related]
18. Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis.
Suehara N; Mizumoto K; Tanaka M; Niiyama H; Yokohata K; Tominaga Y; Shimura H; Muta T; Hamasaki N
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2479-83. PubMed ID: 9815650
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of the expression of MUC4 mRNA in peripheral blood mononuclear cells of pancreatic cancer patients].
Li XH; Xiong JX; Wang CY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):624-7. PubMed ID: 16274046
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic juice cytology and subclassification of intraductal papillary mucinous neoplasms of the pancreas.
Hibi Y; Fukushima N; Tsuchida A; Sofuni A; Itoi T; Moriyasu F; Mukai K; Aoki T
Pancreas; 2007 Mar; 34(2):197-204. PubMed ID: 17312458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
